MedTrace Logo

CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients

NCT02139072 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-10-04

No results posted yet for this study

Summary

The purpose of this study is to see if the CoaguChek XS is accurate in measuring International Normalized Ratio (INR) in patients with Antiphospholipid Antibody Syndrome (APL) receiving warfarin therapy.

Conditions

  • Antiphospholipid Antibody Syndrome

Interventions

DEVICE

CoaguChek XS

CoaguChek XS will be used to measure INR in patients with APL

PROCEDURE

Standard Lab Draw

Patients on warfarin for any indication other than APL will measure INR by venous lab draw

Sponsors & Collaborators

Principal Investigators

  • James Taylor, PharmD · University of Florida

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02139072 on ClinicalTrials.gov